Vontobel Holding’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-1,710
| Closed | -$208K | – | 1155 |
|
2024
Q4 | $208K | Sell |
1,710
-93
| -5% | -$11.3K | ﹤0.01% | 1006 |
|
2024
Q3 | $225K | Sell |
1,803
-3,281
| -65% | -$410K | ﹤0.01% | 983 |
|
2024
Q2 | $803K | Sell |
5,084
-19,316
| -79% | -$3.05M | ﹤0.01% | 625 |
|
2024
Q1 | $3.16M | Sell |
24,400
-878
| -3% | -$114K | 0.03% | 378 |
|
2023
Q4 | $2.44M | Buy |
25,278
+2,863
| +13% | +$276K | 0.02% | 403 |
|
2023
Q3 | $2.72M | Sell |
22,415
-798
| -3% | -$96.7K | 0.03% | 375 |
|
2023
Q2 | $2.66M | Sell |
23,213
-3,898
| -14% | -$446K | 0.02% | 392 |
|
2023
Q1 | $3.74M | Sell |
27,111
-1,555
| -5% | -$214K | 0.03% | 325 |
|
2022
Q4 | $3.62M | Buy |
28,666
+7,899
| +38% | +$998K | 0.04% | 332 |
|
2022
Q3 | $2.3M | Buy |
20,767
+1,638
| +9% | +$181K | 0.03% | 375 |
|
2022
Q2 | $1.47M | Sell |
19,129
-250
| -1% | -$19.3K | 0.02% | 447 |
|
2022
Q1 | $1.51M | Sell |
19,379
-1,156
| -6% | -$90.3K | 0.01% | 497 |
|
2021
Q4 | $1.85M | Buy |
20,535
+3,165
| +18% | +$285K | 0.02% | 461 |
|
2021
Q3 | $1.61M | Buy |
17,370
+1,064
| +7% | +$98.4K | 0.01% | 494 |
|
2021
Q2 | $1.27M | Buy |
16,306
+4,007
| +33% | +$312K | 0.01% | 542 |
|
2021
Q1 | $917K | Sell |
12,299
-164
| -1% | -$12.2K | 0.01% | 547 |
|
2020
Q4 | $1.19M | Buy |
+12,463
| New | +$1.19M | 0.01% | 466 |
|